Nomad Foods Limited
11.18USD
-0.2800 (-2.44%)
Consensus EPS on the street’s adjusted basis, not the filed GAAP figure — which is why the actuals here can differ from the income statement.
| Period | Consensus EPS | 90 days ago | Revisions up (30d) | Revisions down (30d) |
|---|---|---|---|---|
| Current quarter | $0.45▼ | $0.51 | 0 | 5 |
| Next quarter | $0.35▼ | $0.47 | 0 | 5 |
| Current year | $1.43▼ | $1.51 | 0 | 5 |
| Next year | $1.49▼ | $1.64 | 0 | 5 |
Beat in 4 of the last 4
| Quarter | Estimate | Actual | Surprise |
|---|---|---|---|
| 2026-06-30 | $0.37 | $0.39 | +0.02 (+4.7%) |
| 2026-03-31 | $0.19 | $0.23 | +0.04 (+24.0%) |
| 2025-12-31 | $0.43 | $0.43 | +0.00 (+0.3%) |
| 2025-09-30 | $0.47 | $0.49 | +0.02 (+5.1%) |
76 ratings from 13 firms
Ratings are attributed to the research firm, not to individual analysts. See every ticker.
| Firm | Action | Rating | Price Target | Date |
|---|---|---|---|---|
| BTIG | Reiterated | Buy | $15 | Aug 14, 2026 |
| Barclays | Maintained | Overweight | $12 $14 | Jul 21, 2026 |
| BTIG | Reiterated | Buy | $15 | May 13, 2026 |
| Barclays | Maintained | Overweight | $13 $12 | Apr 15, 2026 |
| Deutsche Bank | Downgraded from Buy | Hold | $15 $10 | Mar 30, 2026 |
| Mizuho | Maintained | Outperform | $15 $13 | Mar 3, 2026 |
| Barclays | Maintained | Overweight | $15 $13 | Mar 2, 2026 |
| BTIG | Maintained | Buy | $18 $15 | Mar 2, 2026 |
| Mizuho | Maintained | Outperform | $17 $15 | Jan 8, 2026 |
| BTIG | Reiterated | Buy | $18 | Nov 10, 2025 |
| Deutsche Bank | Maintained | Buy | $18 $16 | Nov 7, 2025 |
| BTIG | Maintained | Buy | $20 $18 | Sep 17, 2025 |
| BTIG | Maintained | Buy | $20 $18 | Sep 16, 2025 |
| Mizuho | Maintained | Outperform | $23 $20 | Aug 12, 2025 |
| Barclays | Maintained | Overweight | $20 $18 | Aug 8, 2025 |
| Mizuho | Maintained | Outperform | $26 $23 | Jul 28, 2025 |
| Barclays | Maintained | Overweight | $23 $20 | Jul 15, 2025 |
| Mizuho | Maintained | Outperform | $24 $26 | Mar 4, 2025 |
| Barclays | Maintained | Overweight | $19 $23 | Mar 3, 2025 |
| Barclays | Maintained | Overweight | $21 $19 | Jan 17, 2025 |
| Mizuho | Maintained | Outperform | $28 $24 | Dec 18, 2024 |
| Deutsche Bank | Maintained | Buy | $25 $23 | Nov 4, 2024 |
| Deutsche Bank | Maintained | Buy | $23 $24 | Aug 8, 2024 |
| Barclays | Maintained | Overweight | $22 $21 | Jul 19, 2024 |
| Mizuho | Maintained | Buy | $26 $28 | May 10, 2024 |
11 filings from 9 insiders · 0 buy / 0 sell over 6m
Officers and directors of NOMD, from the last two years of filings. Grants, gifts and option exercises are shown but not colour-coded — they are compensation, not a view on the price.
| Insider | Action | Shares | Price | Value | Date |
|---|---|---|---|---|---|
| BRISBY DOMINIC JAMESChief Executive Officer | Buy | 50.0k | $12.38 | $619k | Aug 24, 2026 |
| BALDEW RUBEN SEWNARAINChief Financial Officer | Buy | 28.3k | $11.85 | $335k | Aug 19, 2026 |
| LILLIE JAMES EDirector | Grant | 14.0k | — | — | Jun 22, 2026 |
| DORMAN CAREY JDirector | Grant | 22.7k | — | — | Jun 22, 2026 |
| STACK MELANIE DAWNDirector | Grant | 21.9k | — | — | Jun 22, 2026 |
| PILOWSKY AMITDirector | Grant | 21.7k | — | — | Jun 22, 2026 |
| PARRY VICTORIADirector | Grant | 14.0k | — | — | Jun 22, 2026 |
| BRISBY DOMINIC JAMESChief Executive Officer | Buy | 150.0k | $9.79 | $1.47M | May 15, 2026 |
| BALDEW RUBEN SEWNARAINChief Financial Officer | Buy | 14.7k | $9.71 | $143k | May 14, 2026 |
| ASHKEN IAN G HDirector | Buyindirect | 100.0k | $9.13 | $913k | May 13, 2026 |
| GOTTESMAN NOAMChairman of the Board | Buyindirect | 700.0k | $9.23 | $6.63M | May 12, 2026 |
No analyst notes on NOMD yet.
Analyst Ratings
5 analysts covering
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Consensus |
|---|---|---|---|---|---|---|
| Current | 2 | 2 | 1 | 0 | 0 | Buy1.80 |
| 1 mo ago | 2 | 2 | 1 | 0 | 0 | Buy1.80 |
| 2 mo ago | 2 | 2 | 1 | 0 | 0 | Buy1.80 |